Skip to main content

Safety Alerts

By
VIROLOGICAL FAILURE IN HIV PATIENTS TREATED WITH THE COMBINATION OF DIDANOSINE, LAMIVUDINE AND TENOFOVIR
The World Health Organisation (WHO) in collaboration with the European Medical Evaluation Agency (EMEA), have issued a public statement warning about the high rate of Virologic failure in HIV patients treated with a triple nucleoside/nucleotide reverse transcriptase inhibitors combination containing Didanosine, Lamivudine and Tenofovir.
The warning statement is based on the observation of a high rate of virologic failure in a clinical study of HIV-infected patients receiving a once-day triple combination containing tenofovir (Viread, TDF), lamivudine (Epivir, 3TC) and enteric coated bedlets (Videx EC, ddI EC)
In the meantime doctors are advised as precautionary measure, NOT to use Tenofovir in combination with Didanosine and Lamivudine  when considering a new treatment regimen for therapy or treatment experienced HIV patients.
Patients already on therapy with above combination should be frequently monitored with a viral load test and considered for modification of therapy at first sign of viral load increase.
The precise nature of any interaction leading to non-response is currently unknown and is being investigated.
For further information contact TFDA
COUNTERFEIT TRIPLE ARV COMBINATION PRODUCT (GINOVIR 3D)
The Tanzania Food and Drugs Authority (TFDA) has received a warning information from the World Health Organisation (WHO) on the presence of counterfeit triple antiretroviral combination product, Ginovir 3D capsules, in Cote d’Ivoire.
The label of the medicines showed that each capsule of Ginovir 3D contained Zidovudine (200 mg), Lamivudine (150 mg) and Indinavir (40 mg). Laboratory tests however, did not show the presence of Lamivudine or Indinavir; the capsules were found to contain 201 mg of Zidovudine and 40 mg of Stavudine in addition to a non-identified substance. Labels indicated that the products were manufactured by Selchi Pharmaceuticals, P. O. Box 3351, WINDHOEK, Namibia.
TFDA would like to pass this warning statement to health care providers and the public in general as precautionary measure to stay alert to the possible presence of this product in our market.
Please communicate with TFDA once you see a similar product.

Comments

Post a Comment

Popular posts from this blog

CAREER PATH EVENT - 3rd AUGUST 2018 (Photos)

By
1 comment
Read more

Pharmacy council recognises KIU courses, says Registrar

By
6th June 2015 Kampala International University (KIU) The Pharmacy Council of Tanzania has made it clear that it recognizes courses offered by the Kampala International University (KIU), Tanzania Branch, thus students graduating from the Gongolamboto campus will be registered by the professional body accordingly. Giving the go-ahead notice, the pharmacists’ council early this week issued an official letter to the KIU management setting out cardinal terms to be followed by graduating students to attain full registration as professional practitioners. A letter inked by the council’s registrar, Ms Elizabeth Shekalaghe dated 28th May 2015, with Ref. No.AB300/321/02/22 states that the move follows the university’s application for approval of providing pharmacy education and training “since your university has been recognized by the Tanzania Commission for Universities (TCU) as constituent college of KIU Kampala... All the enrolled Bachelor of Pharmacy De...
Post a Comment
Read more

WORLD PHARMACIST DAY 2015 - Theme: Pharmacist(s): your partner(s) in health”

By
All over the world, on Friday 25 September, pharmacists celebrate World Pharmacists Day. This special day, now in its fifth year, was established by the International Pharmaceutical Federation (FIP), the global federation of national associations of pharmacists and pharmaceutical scientists, which is in official relations with the World Health Organization. . The purpose of World Pharmacists Day is to encourage activities that promote and advocate for the role of the pharmacist in improving health in every corner of the world. This year’s theme, developed by FIP, is “ Pharmacist(s): your partner(s) in health” .  Medicines must go hand in hand with pharmaceutical expertise, or in other words, with pharmacists. This partnership is essential to the responsible use of medicines. But other partnerships are also important. Every day three million pharmacists and pharmaceutical scientists around the world act as partners to patients, other health care professionals and other...
1 comment
Read more